Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze BCYC stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BCYC investment potential.

What is BCYC stock price today?

Get real-time BCYC stock price, historical data, and price charts on Financhill. Track BCYC performance with our advanced analysis tools.

Is BCYC a good investment?

Evaluate BCYC investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BCYC stock?

To buy BCYC stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BCYC?

View detailed market capitalization data and company valuation metrics for BCYC on our comprehensive analysis page.

What is the P/E ratio of BCYC?

Use our fundamental analysis tools to view BCYC P/E ratio and compare valuation metrics with industry peers.

What are BCYC earnings?

View BCYC earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Bicycle Therapeutics Plc 10K Form

Sell

BCYC
Bicycle Therapeutics Plc

Last Price:

$5.06

Seasonality Move:

-2.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-11-05	10Q	BCYC/Bicycle Therapeutics Plc Quarterly
2020-08-05	10Q	BCYC/Bicycle Therapeutics Plc Quarterly
2020-05-07	10Q	BCYC/Bicycle Therapeutics Plc Quarterly
2020-03-10	10K	BCYC/Bicycle Therapeutics Plc Annual
2019-11-07	10Q	BCYC/Bicycle Therapeutics Plc Quarterly
2019-08-08	10Q	BCYC/Bicycle Therapeutics Plc Quarterly

Receive BCYC News And Ratings

See the #1 stock for the next 7 days that we like better than BCYC

BCYC Financial Statistics

Sales & Book Value

Annual Sales:	$72.8M
Cash Flow:	$-19.7M
Price / Cash Flow:	0
Annual Sales:	$8.79
Price / Book:	0.83

Profitability

EPS (TTM):	-3.17310
Net Income (TTM):	$-219.8M
Gross Margin:	$66.3M
Return on Equity:	-32.03%
Return on Assets:	-26.45%

Bicycle Therapeutics Plc Earnings Forecast

Key Bicycle Therapeutics Plc Financial Ratios

The Gross Profit Margin over the past 10 years for BCYC is 91.15%.
The Selling, General & Administrative Expenses for BCYC have been equal to 109.34% of Gross Profit Margin.
The Research & Development expenses have been 379.14% of Revenue.
The Net Earning history of BCYC is -301.66% of Total Revenues.
Per Share Earnings over the last 10 years have been positive in 4 years.

Bicycle Therapeutics Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	BCYC
CUSIP:	088786
Website:	bicycletherapeutics.com

Debt

Debt-to-Equity Ratio:	0.03
Current Ratio:	11.98
Quick Ratio:	11.03

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

BCYC Technical Analysis vs Fundamental Analysis